Qi Qu1, Tao Zhang1, Xue-Qin Zhang1, Meng-Tian Lu1, Lei Xu1, and Xian-Ce Zhao2
1Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People’s Hospital, Nantong, Jiangsu, China, Nantong, China, 2Philips Healthcare, Shanghai, China, Shanghai, China
Synopsis
Keywords: Liver, Cancer
To assess the
predictive value of preoperative gadoxetic acid (GA)-enhanced magnetic
resonance imaging (MRI) features and postoperative histopathological grading
for early recurrence of hepatocellular carcinoma (HCC) without microvascular
invasion (MVI) after curative hepatectomy. The results of
the present demonstrated that our predictive model incorporating postoperative
Edmondson-Steiner grade and preoperative imaging features including peritumoral
hypointensity on HBP and RIR on HBP (Model-2) represents a promising model to
assess the risk of early recurrence after resection of MVI-negative HCC. This
predictive model may help clinicians formulate more aggressive and personalised
treatment plans way earlier to improve patient prognosis and reduce early
recurrence.
INTRODUCTION
MVI-negative HCC
cases, an important subset of patients who may undergo curative liver
resection, are also susceptible to early recurrence. However, studies that
specifically evaluate predictors of poor postoperative prognoses (e.g., early
recurrence) in MVI-negative HCC remains limited.1,2 In addition to
the postoperative histopathological grading,1 preoperative MRI
features2 have been reported to be correlated to early relapse and
poor survival in HCC patients without MVI; these imaging features include as
mosaic architecture, larger tumor size, and non-smooth tumor margins. Of note,
imaging features of the hepatobiliary phase (HBP) was not incorporated in that
study due to limitations of the contrast agent, gadolinium-diethylenetriamine
pentaacetic acid (Gd-DTPA).2 Therefore, the parameters and
predictive models involving imaging and histopathological data remain to be
perfected and validated so that reliable predictive models can be made
available to clinicians for them to better implement adjuvant therapy and to
design clinical trials. To that end, the present retrospective study was aimed
to establish a refined predictive model to predict early recurrence in
MVI-negative HCC patients, by comparing a preoperative prediction model solely
based on gadoxetic acid (GA)-enhanced MRI parameters (Model-1) and an
integrated model involving both preoperative MRI features and postoperative
histopathological measures (Model-2). METHODS
A total of 85 MVI-negative HCC cases were
retrospectively analyzed, among which 28 showed early recurrence of HCC within
24 months after surgery and 57 did not exhibit recurrent HCC during the cut-off
latency (24 months). All patients were performed non-enhanced and Gd-EOB-DTPA-enhanced
MRI of liver. Abdominal MRI was performed using a Philips 3.0 T Achieva MR
scanner with a 16-channel abdominal coil. In Gd⁃EOB⁃DTPA⁃enhanced MRI,
qualitative indicators including whether the tumor signal was uniform,
peritumoral enhancement, tumor capsule, tumor margin, peritumor hypointensity
and presence of fat in the tumor were assessed, etc. Quantitative indicators
including the relative intensity ratio (RIR) of post⁃enhancement arterial
phase, portal vein phase, transitional phase and hepatobiliary phase were
assessed and recorded. Interreader agreement was evaluated by using intraclass
correlation coefficient (ICC). RESULTS
Edmondson-Steiner grade, peritumoral hypointensity on
hepatobiliary phase (HBP), and RIR in HBP were identified
as independent variables associated with early recurrence. The C-index of the
nomogram models and internal validation were both between 0.7 and 0.8, showing
good model fitting and calibration effects. The area under the ROC curve (AUC)
was 0.781 for Model-1 based on the two preoperative MRI factors. When a third
factor, the Edmondson-Steiner grade, was included (Model-2), the AUC increased
to 0.834, and the sensitivity increased from 71.4% to 96.4%.DISCUSSION
we found that HBP
peritumoral hypointensity was a useful predictor for the early recurrence of
MVI-negative HCC, and this sign could be observed more frequently in the ER
group. In view of the correlation between GA-enhanced MRI, an indirect
molecular imaging method, and the molecular biology of tumor regulatory
mechanisms,3 we believed that this sign may reveal the malignant
potential of tumors. However, in this study, the sensitivity of peritumoral
hypointensity on HBP to predict early recurrence of MVI-negative HCC was
relatively low. We speculated that this may be because the tumor was not
accompanied by microvascular invasion and that changes in blood perfusion and
hepatocyte function around the tumor were relatively small. Studies
have reported that poorly differentiated tumors have a negative impact on the
recurrence risk and long-term survival of patients with HCC after radical liver
resection.4,5 Under the Edmondson-Steiner grading system,
MVI-negative HCC with different degrees of differentiation have been confirmed
to be significantly associated with poor postoperative outcomes.1
This is consistent with our study where patients with poorly differentiated HCC
appeared more prone to early recurrence than those with
well-differentiated/moderately differentiated HCC. Studies have shown that HCC
tissues with low expression of OATP1B3 potentially have an advanced TNM stage,
a lower degree of tumor differentiation, and a higher risk of recurrence.6,7
Based on this conclusion, which attracted us to further explore this biomarker,
new ideas for individualised medicine in liver cancer treatment may germinate.
In the multivariate
analysis, the quantitative imaging parameter RIR value in the hepatobiliary
phase was negatively correlated with the postoperative ER; that is, with a
decrease in the RIR value, the ER rate increased significantly. Ye et al8
showed that HCC with a lower tumor-to-liver SI ratio on HBP exhibited significantly
reduced OATP expression levels and worse prognosis, including higher
aggressiveness, higher tumor grade, and shorter recurrence-free survival.
We postulated that this
quantitative index could establish a correlation between the imaging features
and the biological behaviour of tumors. It may be possible to non-invasively
and effectively predict tumor response to treatment and the likelihood of early
recurrence. The emergence of some quantitative parameters may represent greater
value in predicting early postoperative recurrence of HCC, which deserved
future investigation.CONCLUSIONS
Edmondson-Steiner
grade, peritumoral hypointensity on HBP, and RIR in HBP can help predict early
recurrence of MVI-negative HCC. In comparison to Model-1 (only imaging
features), Model-2 (imaging features+ histopathological grades) increases the
sensitivity in predicting early recurrence of HCC without MVI.Acknowledgements
Thanks to all the people who have devoted their time and efforts to this article, especially Professor Zhang Xueqin and Professor Zhang Tao, and thanks to Philips for providing technical support for this research.References
1. Zhou L, Rui JA, Zhou
WX, et al. Edmondson-Steiner grade: A crucial predictor of recurrence and
survival in hepatocellular carcinoma without microvascular invasio[J]. Pathol
Res Pract, 2017, 213:824-30.
2. Wei Y, Pei W,
Qin Y, et al. Preoperative MR imaging for predicting early recurrence of
solitary hepatocellular carcinoma without microvascular invasion[J]. Eur J
Radiol, 2021, 138:109663.
3. Kitao A, Matsui
O, Yoneda, et al. Gadoxetic acid-enhanced MR imaging for hepatocellular
carcinoma: molecular and genetic background[J]. Eur Radiol, 2020, 30:3438-47.
4. Shen J, Liu J,
Li C, et al. The Impact of Tumor Differentiation on the Prognosis of
HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A
Propensity Score Matching Analysis[J]. Dig Dis Sci, 2018, 63:1962-69.
5. Chen W, Zhang Z, Fang X, et al.
Prognostic value of the ALBI grade among patients with single hepatocellular
carcinoma without macrovascular invasion[J]. Medicine (Baltimore), 2021, 100:e26265.
6. Kitao A, Matsui O, Yoneda N, et al. The
uptake transporter OATP8 expression decreases during multistep
hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging[J].
Eur Radiol, 2011, 21:2056-66.
7. Chen S, Li K, Jiang J, Wang X, Chai Y,
Zhang C, et al. Low expression of organic anion-transporting polypeptide 1B3
predicts a poor prognosis in hepatocellular carcinoma[J]. World J Surg Oncol,
2020, 18:127.
8. Ye Z, Cao L, Wei Y, et al. Preoperative
prediction of hepatocellular carcinoma with highly aggressive characteristics
using quantitative parameters derived from hepatobiliary phase MR images[J].
Ann Transl Med, 2020, 8:85.